No abstract available
MeSH terms
-
Clinical Trials, Phase III as Topic
-
Disease Progression
-
Dyspnea / etiology
-
Dyspnea / prevention & control
-
Endpoint Determination
-
Exercise Test
-
Guanylate Cyclase / metabolism
-
Humans
-
Hypertension, Pulmonary / blood
-
Hypertension, Pulmonary / classification
-
Hypertension, Pulmonary / complications
-
Hypertension, Pulmonary / drug therapy*
-
Natriuretic Peptide, Brain / blood
-
Peptide Fragments / blood
-
Pyrazoles / administration & dosage
-
Pyrazoles / pharmacology
-
Pyrazoles / therapeutic use*
-
Pyrimidines / administration & dosage
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Vascular Resistance / drug effects
-
Walking
-
World Health Organization
Substances
-
Peptide Fragments
-
Pyrazoles
-
Pyrimidines
-
pro-brain natriuretic peptide (1-76)
-
Natriuretic Peptide, Brain
-
Guanylate Cyclase
-
riociguat